CBIO vs GD · $491.3M cap vs P/E 22, rev $52.55B
Crescent Biopharma, Inc. (CBIO) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
CBIO does not have a complete income-statement cache yet.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
CBIO currently screens at market cap $491.3M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the CBIO and GD stock pages for the full models.
Not investment advice.